This inventor holds 2 USPTO granted patents. Top assignee: Teikoku Seiyaku Co., Ltd.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Innovations by Seiichi Sako: Pioneering Intravaginal Drug Delivery
Introduction: Seiichi Sako, an accomplished inventor based in Anan, Japan, has made significant contributions to the field of pharmaceutical compositions. With two patents to his name, Sako's work focuses on innovative drug delivery methods, particularly in the realm of intravaginal administration of biologically active polypeptides.
Latest Patents: Among Sako's notable patents is a groundbreaking formulation for the intravaginal delivery of biologically active polypeptides. His patent outlines a pharmaceutical composition comprising a biologically active polypeptide, an absorption promoter such as anionic or nonionic surfactants, and optionally, an animal or vegetable protein. A nontoxic, pharmaceutically acceptable carrier or diluent is also integrated into the formulation. Preferred compositions highlighted in his patent include calcitonin as the biologically active polypeptide, while sodium lauryl sulfate serves as an effective anionic surfactant. Additionally, the combination of a nonionic surfactant and a medium chain aliphatic carboxylic acid further enhances absorption, showcasing Sako's innovative approach to drug delivery.
Career Highlights: Seiichi Sako is affiliated with Teikoku Seiyaku Co., Ltd., a prominent company in the pharmaceutical sector. His expertise in developing advanced drug formulations has positioned him as a key figure within the organization, contributing to its reputation for innovation in healthcare solutions.
Collaborations: Sako has worked alongside skilled colleagues such as Takeru Fujii and Shigeyuki Takama. These collaborations have fostered a dynamic environment for creative ideas and technological advancements in the field of pharmaceuticals, leading to impactful innovations that enhance patient care.
Conclusion: Seiichi Sako's contributions to the pharmaceutical industry exemplify the role of inventors in pushing the boundaries of medical science. His patented formulations for intravaginal delivery of biologically active polypeptides represent significant advancements in drug delivery systems, showcasing the innovative spirit that drives progress in healthcare. As he continues his work at Teikoku Seiyaku Co., Ltd., the potential for future innovations remains promising.